Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Alzheimer's disease (AD) is a progressive brain disorder that gradually destroys memory and cognitive abilities, affecting ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Share on PinterestMore evidence suggests that semaglutide drugs could help lower the risk of Alzheimer’s disease. Image ...

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia?

Compared to other diabetes medications, semaglutide might offer added protection against Alzheimer’s for type 2 diabetes ...